A detailed history of Geode Capital Management, LLC transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,927,196 shares of LH stock, worth $392 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,927,196
Previous 1,870,479 3.03%
Holding current value
$392 Million
Previous $425 Million 0.97%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$209.01 - $232.56 $11.9 Million - $13.2 Million
56,717 Added 3.03%
1,927,196 $421 Million
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $9.54 Million - $11 Million
-48,248 Reduced 2.51%
1,870,479 $425 Million
Q3 2023

Nov 13, 2023

BUY
$201.05 - $221.7 $8.56 Million - $9.44 Million
42,583 Added 2.27%
1,918,727 $386 Million
Q2 2023

Aug 11, 2023

BUY
$211.93 - $241.33 $7.01 Million - $7.99 Million
33,093 Added 1.8%
1,876,144 $453 Million
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $5.59 Million - $6.75 Million
26,197 Added 1.44%
1,843,051 $423 Million
Q4 2022

Feb 13, 2023

SELL
$203.72 - $248.97 $4.17 Million - $5.09 Million
-20,461 Reduced 1.11%
1,816,854 $427 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $10.1 Million - $12.9 Million
-49,362 Reduced 2.62%
1,837,315 $376 Million
Q2 2022

Aug 12, 2022

BUY
$213.86 - $277.87 $4.8 Million - $6.24 Million
22,461 Added 1.2%
1,886,677 $442 Million
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $3.28 Million - $3.76 Million
-12,611 Reduced 0.67%
1,864,216 $491 Million
Q4 2021

Feb 11, 2022

BUY
$271.6 - $314.21 $11.3 Million - $13.1 Million
41,781 Added 2.28%
1,876,827 $588 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $16.2 Million - $18.2 Million
59,057 Added 3.33%
1,835,046 $515 Million
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $16.6 Million - $18.3 Million
65,973 Added 3.86%
1,775,989 $489 Million
Q1 2021

May 12, 2021

BUY
$204.88 - $255.03 $16.6 Million - $20.6 Million
80,880 Added 4.96%
1,710,016 $435 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $14.2 Million - $16.2 Million
75,765 Added 4.88%
1,629,136 $331 Million
Q3 2020

Nov 13, 2020

BUY
$167.03 - $201.3 $2.19 Million - $2.64 Million
13,103 Added 0.85%
1,553,371 $292 Million
Q2 2020

Aug 13, 2020

BUY
$113.31 - $182.44 $2.71 Million - $4.37 Million
23,934 Added 1.58%
1,540,268 $255 Million
Q1 2020

May 14, 2020

BUY
$104.32 - $195.28 $2.68 Million - $5.01 Million
25,654 Added 1.72%
1,516,334 $191 Million
Q4 2019

Feb 13, 2020

BUY
$163.48 - $173.61 $7.82 Million - $8.3 Million
47,834 Added 3.32%
1,490,680 $252 Million
Q3 2019

Nov 12, 2019

BUY
$159.77 - $178.1 $6.04 Million - $6.73 Million
37,789 Added 2.69%
1,442,846 $242 Million
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $4.37 Million - $5.24 Million
-30,311 Reduced 2.11%
1,405,057 $243 Million
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $2.88 Million - $3.64 Million
23,275 Added 1.65%
1,435,368 $219 Million
Q4 2018

Feb 13, 2019

BUY
$120.82 - $174.09 $13.5 Million - $19.5 Million
111,859 Added 8.6%
1,412,093 $178 Million
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $4.41 Million - $4.95 Million
26,275 Added 2.06%
1,300,234 $225 Million
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $9.49 Million - $11.2 Million
59,200 Added 4.87%
1,273,959 $228 Million
Q1 2018

May 15, 2018

BUY
$161.53 - $178.11 $15.7 Million - $17.3 Million
97,330 Added 8.71%
1,214,759 $196 Million
Q4 2017

Feb 13, 2018

BUY
$147.99 - $163.95 $5.29 Million - $5.86 Million
35,722 Added 3.3%
1,117,429 $178 Million
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $4.92 Million - $5.29 Million
32,933 Added 3.14%
1,081,707 $163 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,048,774
1,048,774 $161 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.2B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.